Association Between Gut Microbial Diversity and Carotid Intima-Media Thickness
Overview
Authors
Affiliations
There is an increasing focus on the effect of the gut microbiome on developing atherosclerosis, but there is still no unified standpoint. We aimed to find associations between intestinal microbiome diversity and a marker of subclinical atherosclerosis, the carotid intima-media thickness (IMT). Recruited from the Hungarian Twin Registry, 108 monozygotic (MZ) twins (mean age 52.4 ± 14.1 years, 58% female) underwent a comprehensive carotid ultrasound examination (Samsung RS85). Of the 108 MZ twins, 14 pairs (mean age 65 ± 6.4 years, 71% female) discordant for carotid IMT were selected to undergo a stool sample collection. A special stool sampling container was mailed and received from each participant. After DNA extraction, library construction was performed specifically for the V3-V4 hypervariable region of microbial 16S rRNA. Next, the microbiome composition of the samples was determined using Kraken software. Two hypotheses were tested with the exact permutation test: (1) in the group with normal IMT, the Shannon index of the phyla is higher; and (2) the Firmicutes/Bacteroidetes ratio is greater in the group with high IMT values. Furthermore, the abundance of different bacterial strains present at higher and normal IMT was also explored. Statistical analysis was carried out using R software. Increased Firmicutes/Bacteroidetes ratio was associated with increased IMT (mean Firmicutes/Bacteroidetes ratio of IMT > 0.9 and IMT < 0.9 groups: 2.299 and 1.436, respectively; = 0.031). In the group with normal IMT values, a substantially higher fraction of was observed in contrast with subjects having subclinical atherosclerosis. However, there was no significant difference in the alpha diversity between the two groups. The determining role of individual genera and their proportions in the development and progression of atherosclerosis can be assumed. Further studies are needed to clarify if these findings can be used as potential therapeutic targets.
Targeting gut microbiota to regulate the adaptive immune response in atherosclerosis.
Giakomidi D, Ishola A, Nus M Front Cardiovasc Med. 2025; 12:1502124.
PMID: 39957996 PMC: 11825770. DOI: 10.3389/fcvm.2025.1502124.
Pala B, Tocci G, Nardoianni G, Barbato E, Amedei A Diagnostics (Basel). 2024; 14(22).
PMID: 39594129 PMC: 11592993. DOI: 10.3390/diagnostics14222463.
Mediation effect of gut microbiota on the relationship between physical activity and carotid plaque.
Ouyang W, Tang B, He Y, Wu H, Yang P, Yin L Front Microbiol. 2024; 15:1432008.
PMID: 39056008 PMC: 11269180. DOI: 10.3389/fmicb.2024.1432008.
Grammatopoulos K, Antoniou V, Mavrothalassitis E, Mouziouras D, Argyris A, Emmanouil E Am Heart J Plus. 2024; 23:100219.
PMID: 38560653 PMC: 10978426. DOI: 10.1016/j.ahjo.2022.100219.
Role of gut microbiota in cardiovascular diseases - a comprehensive review.
Rashid S, Sado A, Afzal M, Ahmed A, Almaalouli B, Waheed T Ann Med Surg (Lond). 2024; 86(3):1483-1489.
PMID: 38463085 PMC: 10923299. DOI: 10.1097/MS9.0000000000001419.